Key Insights

Highlights

Treatment Research

1 treatments under study, led by Saw Palmetto And Sanmiaoshan Capsule

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00497939Not ApplicableUnknown

The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients

Showing all 1 trials

Research Network

Common Treatments

  • Saw Palmetto And Sanmiaoshan Capsule1

Active Sponsors

  • Hospital Authority, Hong Kong1

Top Investigators

  • Chi Fai Ng, Dr1

    Department of Surgery, Division of Urology, The Chinese University of Hong Kong

Related Conditions

  • Prostatic Hyperplasia1

Activity Timeline